Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jolivet

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Lung|October 8, 2005
Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancerS F Dent, A Arnold, D J Stewart, et al.
The New England Journal of Medicine|January 27, 1983
Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomesG A Curt, D N Carney, K H Cowan, et al.
Cancer Research|October 5, 2001
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell linesH Gourdeau, M L Clarke, F Ouellet, et al.
Current Oncology (Toronto, Ont.)|January 5, 2019
Real-world benefit of nivolumab in a Canadian non-small-cell lung cancer cohortR A Juergens, C Mariano, J Jolivet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials GroupC A Townsley, K Chi, D S Ernst, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Lung|October 8, 2005
Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancerS F Dent, A Arnold, D J Stewart, et al.
The New England Journal of Medicine|January 27, 1983
Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomesG A Curt, D N Carney, K H Cowan, et al.
Cancer Research|October 5, 2001
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell linesH Gourdeau, M L Clarke, F Ouellet, et al.
Current Oncology (Toronto, Ont.)|January 5, 2019
Real-world benefit of nivolumab in a Canadian non-small-cell lung cancer cohortR A Juergens, C Mariano, J Jolivet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials GroupC A Townsley, K Chi, D S Ernst, et al.
Pageof 7